Cargando…

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis

Detalles Bibliográficos
Autores principales:	Kang, Seong Hee, Kim, Moon Young, Baik, Soon Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281957/ https://www.ncbi.nlm.nih.gov/pubmed/30534035 http://dx.doi.org/10.3346/jkms.2018.33.e334

Ejemplares similares

Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
por: Kim, Gaeun, et al.
Publicado: (2017)

Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
por: Kang, Seong Hee, et al.
Publicado: (2018)

Sarcopenia as a prognostic indicator of liver cirrhosis
por: Kim, Sung‐Eun, et al.
Publicado: (2021)

Liver cirrhosis and sarcopenia: a dreadful combination
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
por: Cho, Eun Ju, et al.
Publicado: (2015)

Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis
por: Jeong, Jae Yoon, et al.
Publicado: (2018)

Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study
por: Park, Min Sun, et al.
Publicado: (2018)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease
por: Kang, Seong Hee, et al.
Publicado: (2020)

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
por: Ryu, Se Ri, et al.
Publicado: (2021)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Prognostic Assessment and Management of Liver Cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2017)

Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
por: Kang, Seong Hee, et al.
Publicado: (2020)

Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis
por: Hanai, Tatsunori, et al.
Publicado: (2023)

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

Myostatin and beyond in cirrhosis: all roads lead to sarcopenia
por: Dasarathy, Srinivasan
Publicado: (2017)

Mesenchymal stem cells to treat liver diseases
por: Eom, Young Woo, et al.
Publicado: (2020)

Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis
por: Gu, Dae Hoe, et al.
Publicado: (2018)

The sex‐specific prognostic utility of sarcopenia in cirrhosis
por: Lowe, Ryan, et al.
Publicado: (2022)

Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China
por: Zeng, Xin, et al.
Publicado: (2021)

Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
por: Lim, Yoo Li, et al.
Publicado: (2016)

Prognostic implications of trunk muscle mass in liver cirrhosis
por: Han, Jimin, et al.
Publicado: (2018)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Mechanisms of sarcopenia in liver cirrhosis and the role of myokines
por: Geladari, Eleni, et al.
Publicado: (2023)

Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Patients with Cirrhosis and Healthy Volunteers Show Comparable Characteristics
por: Lim, Yoo Li, et al.
Publicado: (2020)

Perspectives on Acute Hepatitis A Control in Korea
por: Kang, Seong Hee, et al.
Publicado: (2019)

Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2021)

Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
por: Xu, Jia-qi, et al.
Publicado: (2023)

Sarcopenia and Liver Cirrhosis—Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019
por: Traub, Julia, et al.
Publicado: (2020)

Consilience in sarcopenia of cirrhosis
por: Dasarathy, Srinivasan
Publicado: (2012)

Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis
por: Ebhohon, Ebehiwele, et al.
Publicado: (2021)

Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators
por: Curakova Ristovska, Elena, et al.
Publicado: (2022)

Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis
por: Moon, Kyoung Min, et al.
Publicado: (2013)

Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis
por: Kim, Moon Young, et al.
Publicado: (2010)

Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
por: Han, Ji Won, et al.
Publicado: (2022)

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis
por: Hiramatsu, Akira, et al.
Publicado: (2019)

Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis
por: Meyer, Fatuma, et al.
Publicado: (2020)

Impact of Sarcopenia on Survival and Clinical Outcomes in Patients With Liver Cirrhosis
por: Topan, Mirabela-Madalina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7n2hatskd4aqn8pn5gf0p47i9v